Derms and Conditions Podcast Episode 50:
From the Research Center to the Clinic: Biologics and Other Systemic Therapies Part 2
Featuring Andrew Blauvelt, MD, MBA | Release Date: April 27, 2023
Subscribe at
In Episode 50 of Derms and Conditions, our host James Q. Del Rosso, DO, continues his conversation with Andrew Blauvelt, MD, MBA, a clinical trials investigator and former President and Owner of the Oregon Medical Research Center. Dr. Blauvelt has conducted almost 200 clinical trials on biologics and JAK inhibitors for the treatment of psoriasis and atopic dermatitis. While part one of this series focused on psoriasis, part two takes a deep dive into new therapies for atopic dermatitis.
